EPIX - Biotech Pre-earnings Run LONGEPIX on the 15-minute chart shows a solid trend up with a set of moving averages as the
guardrails now in a bit of a pullback. The after-hours price action will not appear on the chart
but price jumped 5%. Earnings are anticipated for 2/8 or 2/9 as best as I can tell. Internet
search informa
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.70 USD
−28.54 M USD
0.00 USD
41.72 M
About ESSA Pharma Inc.
Sector
Industry
CEO
David R. Parkinson
Website
Headquarters
Vancouver
Founded
2009
FIGI
BBG0088NJ8D1
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.
EPIX: Bullish FlagBullish Flag
Pros:
Descending volume during formation
PPS above 50MA and 200MA
RS above 0, and ascending
ATR Ascending
R/R ratio above 9
250RSI above 50
200MA ascending
Cons:
Gap may want to get filled
Target:
PT = 52.04$
Thank you to those who donate Coins!
Stay Humble, have fun, make money!
EPIX Big Push Forward - 86% Up IN ONE MONTHESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant p
Newbie. A friend's recommended EPIX. Anyone familiar with it?Everything I read about Essa Pharma (NASDAQ: EPIX) sounds positive. They claim to have a game-changing prostate cancer technology and significant news ahead. But it is very difficult to buys shares because the 1M float seems tightly held. Four institutions (BVF, Clarus, Omega, Eventide) own 90% of c
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of EPIX is 1.79 USD — it has increased by 1.13% in the past 24 hours. Watch ESSA Pharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ESSA Pharma Inc. stocks are traded under the ticker EPIX.
EPIX stock has risen by 16.99% compared to the previous week, the month change is a 11.87% rise, over the last year ESSA Pharma Inc. has showed a −76.01% decrease.
EPIX reached its all-time high on Jun 22, 2015 with the price of 245.00 USD, and its all-time low was 1.40 USD and was reached on Oct 11, 2022. View more price dynamics on EPIX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EPIX stock is 4.62% volatile and has beta coefficient of 1.95. Track ESSA Pharma Inc. stock price on the chart and check out the list of the most volatile stocks — is ESSA Pharma Inc. there?
Today ESSA Pharma Inc. has the market capitalization of 79.46 M, it has increased by 7.24% over the last week.
Yes, you can track ESSA Pharma Inc. financials in yearly and quarterly reports right on TradingView.
ESSA Pharma Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
EPIX earnings for the last quarter are −0.19 USD per share, whereas the estimation was −0.18 USD resulting in a −5.56% surprise. The estimated earnings for the next quarter are −0.19 USD per share. See more details about ESSA Pharma Inc. earnings.
ESSA Pharma Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
EPIX net income for the last quarter is −8.53 M USD, while the quarter before that showed −6.36 M USD of net income which accounts for −34.25% change. Track more ESSA Pharma Inc. financial stats to get the full picture.
No, EPIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 21, 2025, the company has 35 employees. See our rating of the largest employees — is ESSA Pharma Inc. on this list?
Like other stocks, EPIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ESSA Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ESSA Pharma Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ESSA Pharma Inc. stock shows the sell signal. See more of ESSA Pharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.